Recomendation_2017_30_10_2017_HR

КЛИНИЧЕСКИЕРЕКОМЕНДАЦИИПОПРОВЕДЕНИЮ ЭЛЕКТРОФИЗИОЛОГИЧЕСКИХПРОЦЕДУР УПАЦИЕНТОВСНАРУШЕНИЯМИРИТМАСЕРДЦА

329.Stan M. N.,Hess E. P.,Bahn R. S.,etal.(2012)Ariskpredictionindex foramiodarone-inducedthyrotoxicosisinadultswithcongenitalheart disease.JThyroidRes2012:210529.

330.Pass R. H., Liberman L., Al-Fayaddh M., et al. (2000) Continuous intravenousdiltiazeminfusionforshort-termventricularratecontrol inchildren.AmJCardiol86:559–562,A9.

331.Garnock-JonesK.P.(2012)Esmolol:areviewofitsuseintheshort- termtreatmentoftachyarrhythmiasandtheshort-termcontrolof tachycardiaandhypertension.Drugs72:109–132.

332.Giamberti A., Chessa M., Abella R., et al. (2008) Surgical treatment ofarrhythmiasinadultswithcongenitalheartdefects.IntJCardiol 129:37–41.

333.Stulak J. M., Dearani J. A., Puga F. J., et al. (2006) Right-sided Maze procedure for atrial tachyarrhythmias in congenital heart disease. AnnThoracSurg81:1780–1784.

334.MavroudisC.,Deal B. J.,Backer C. L.,etal.(2008)Arrhythmiasurgery in patients with and without congenital heart disease. Ann Thorac Surg86:857–868.

335.Karamlou T., Silber I., Lao R., et al. (2006) Outcomes after late reoperationinpatientswithrepairedtetralogyofFallot:theimpact ofarrhythmiaandarrhythmiasurgery.AnnThoracSurg81:1786–1793.

336.Deal B. J., Mavroudis C., Backer C. L., et al. (2002) Comparison of anatomicisthmusblockwiththemodifiedrightatrialmazeprocedure forlateatrialtachycardiainFontanpatients.Circulation106:575–579.

337.MavroudisC.,Backer C. L.,Deal B. J.,etal.(2001)Totalcavopulmonary conversionandmazeprocedureforpatientswithfailureoftheFontan operation.JThoracCardiovascSurg122:863–871.

338.MavroudisC.,Deal B. J.,Backer C. L.,etal.(2007)J. MaxwellChamberlain MemorialPaperforcongenitalheartsurgery.111Fontanconversions witharrhythmiasurgery:surgicallessonsandoutcomes.AnnThorac Surg84:1457–1465.

339.Aboulhosn J., Williams R., Shivkumar K., et al. (2010) Arrhythmia recurrenceinadultpatientswithsingleventriclephysiologyfollowing surgicalFontanconversion.CongenitHeartDis5:430–434.

340.Said S. M.,Burkhart H. M.,Schaff H. V.,etal.(2014)Fontanconversion: identifyingthehigh-riskpatient.AnnThoracSurg97:2115–2121.

341.Gutierrez S. D., Earing M. G., Singh A. K., et al. (2013) Atrial tachyarrhythmiasandtheCox-mazeprocedureincongenitalheart disease.CongenitHeartDis8:434–439.

441

ГЛАВА3

342.Terada T., Sakurai H., Nonaka T., et al. (2013) Surgical outcome of Fontanconversionandarrhythmiasurgery:needapacemaker?Asian CardiovascThoracAnn22:682–686.

343.Theodoro D. A.,Danielson G. K.,Porter C. J.,etal.(1998)Right-sided mazeprocedureforrightatrialarrhythmiasincongenitalheartdisease. AnnThoracSurg65:149–153.

344.Silka M. J., Manwill J. R., Kron J., et al. (1990) Bradycardia-mediated tachyarrhythmiasincongenitalheartdiseaseandresponsestochronic pacingatphysiologicrates.AmJCardiol65:488–493.

345.RagoneseP.,DragoF.,GuccioneP.,etal.(1997)Permanentoverdrive atrialpacinginthechronicmanagementofrecurrentpostoperative atrialreentranttachycardiainpatientswithcomplexcongenitalheart disease.PacingClinElectrophysiol20:2917–2923.

346.hotanA.,OstrzegaE.,MehraA.,etal.(1997)Incidenceofarrhythmiasin normalpregnancyandrelationtopalpitations,dizziness,andsyncope. AmJCardiol79:1061–1064.

347.Silversides C. K.,HarrisL.,HabererK.,etal.(2006)Recurrenceratesof arrhythmiasduringpregnancyinwomenwithprevioustachyarrhythmia andimpactonfetalandneonataloutcomes.AmJCardiol97:1206– 1212.

348.Ghosh N., Luk A., Derzko C., et al. (2011) The acute treatment of maternalsupraventriculartachycardiasduringpregnancy:areview oftheliterature.JObstetGynaecolCan33:17–23.

349.Qasqas S. A.,McPhersonC.,Frishman W. H.,etal.(2004)Cardiovascular pharmacotherapeuticconsiderationsduringpregnancyandlactation. CardiolRev12:201–221.

350.Allen N. M., Page R. L. (1993) Procainamide administration during pregnancy.ClinPharm12:58–60.

351.Bartalena L., Bogazzi F., Braverman L. E., et al. (2001) Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment. J Endocrinol Invest 24:116–130.

352.Ersbøll A. S.,HedegaardM.,SøndergaardL.,etal.(2014)Treatment withoralbeta-blockersduringpregnancycomplicatedbymaternal heart disease increases the risk of fetal growth restriction. BJOG 121:618–626.

353.SzumowskiL.,SzufladowiczE.,OrczykowskiM.,etal.(2010)Ablationof severedrug-resistanttachyarrhythmiaduringpregnancy.JCardiovasc Electrophysiol21:877–882.

442

КЛИНИЧЕСКИЕРЕКОМЕНДАЦИИПОПРОВЕДЕНИЮ ЭЛЕКТРОФИЗИОЛОГИЧЕСКИХПРОЦЕДУР УПАЦИЕНТОВСНАРУШЕНИЯМИРИТМАСЕРДЦА

354.DamilakisJ.,TheocharopoulosN.,PerisinakisK.,etal.(2001)Conceptus radiation dose and risk from cardiac catheter ablation procedures. Circulation104:893–897.

355.Porter M. J., Morton J. B., Denman R., et al. (2004) Influence of age andgenderonthemechanismofsupraventriculartachycardia.Heart Rhythm1:393–396.

356.KaluscheD.,OttP.,ArentzT.,etal.(1998)AVnodalre-entrytachycardia inelderlypatients:clinicalpresentationandresultsofradiofrequency catheterablationtherapy.CoronArteryDis9:359–363.

357.Haghjoo M., Arya A., Heidari A., et al. (2007) Electrophysiologic characteristics and results of radiofrequency catheter ablation in elderlypatientswithatrioventricularnodalreentranttachycardia.J Electrocardiol40:208–213

358.Chen S. A.,Lee S. H.,Wu T. J.,etal.(1995)Initialonsetofaccessory pathway-mediatedandatrioventricularnodereentranttachycardia afterage65:clinicalfeatures,electrophysiologiccharacteristics,and possiblefacilitatingfactors.JAmGeriatrSoc43:1370–1377.

359.Chen S. A., Chiang C. E., Tai C. T., et al. (1996) Complications of diagnosticelectrophysiologicstudiesandradiofrequencycatheter ablation in patients with tachyarrhythmias: an eight-year survey of 3,966 consecutive procedures in a tertiary referral center. Am J Cardiol77:41–46.

360.Zado E. S.,Callans D. J.,Gottlieb C. D.,etal.(2000)Efficacyandsafety ofcatheterablationinoctogenarians.JAmCollCardiol35:458–462.

361.Rostock T., Risius T., Ventura R., et al. (2005) Efficacy and safety of radiofrequencycatheterablationofatrioventricularnodalreentrant tachycardiaintheelderly.JCardiovascElectrophysiol16:608–610

362.KihelJ.,DaCostaA.,KihelA.,etal.(2006)Long-termefficacyandsafety of radiofrequency ablation in elderly patients with atrioventricular nodalre-entranttachycardia.Europace8:416–420.

363.DagresN.,PiorkowskiC.,KottkampH.,etal.(2007)Contemporary catheter ablation of arrhythmias in geriatric patients: patient characteristics,distributionofarrhythmias,andoutcome.Europace 9:477–480.

364.Pedrinazzi C., Durin O., Agricola P., et al. (2007) Efficacy and safety of radiofrequency catheter ablation in the elderly. J Interv Card Electrophysiol19:179–185.

443

ГЛАВА3

365.Hoffmann B. A.,BrachmannJ.,AndresenD.,etal.(2011)Ablationof atrioventricularnodalreentranttachycardiaintheelderly:resultsfrom theGermanAblationRegistry.HeartRhythm8:981–987.

366.YangniN’Da’O.,Brembilla-PerrotB.(2008)Clinicalcharacteristicsand managementofparoxysmaljunctionaltachycardiaintheelderly.Arch CardiovascDis101:143–148.

367.Summitt J, Rosenheck S, Kou WH, Schmaltz S, Kadish AH, Morady F. Effectofbasicdrivecyclelengthontheyieldofventriculartachycardia duringprogrammedventricularstimulation.AmJCardiol1990;65:49– 52.

368.Denes P, Uretz E, Ezri MD, Borbola J. Clinical predictors of electrophysiologic findings in patients with syncope of unknown origin.ArchInternMed1988;148:1922–1928.

369.BrignoleM,MenozziC,MoyaA,Garcia-CiveraR,MontL,AlvarezM, Errazquin F, Beiras J, Bottoni N, Donateo P, International Study on Syncope of Uncertain Etiology (ISSUE) Investigators. Mechanism of syncope in patients with bundle branch block and negative electrophysiologicaltest.Circulation2001;104:2045–2050.

370.RoguinA,BommaCS,NasirK,TandriH,TichnellC,JamesC,RutbergJ, CrossonJ,SpevakPJ,BergerRD,HalperinHR,CalkinsH. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventriculardysplasia/cardiomyopathy.JAmCollCardiol2004;43:1843– 1852.

371.BhonsaleA,JamesCA,TichnellC,MurrayB,GagarinD,PhilipsB,Dalal D, Tedford R, Russell SD, Abraham T, Tandri H, Judge DP, Calkins H. Incidenceandpredictorsofimplantablecardioverter-defibrillator therapyinpatientswitharrhythmogenicrightventriculardysplasia/ cardiomyopathy undergoing implantable cardioverter-defibrillator implantationforprimaryprevention.JAmCollCardiol2011;58:1485– 1496.

372.GoldbergerJJ,SubaciusH,PatelT,CunnaneR,KadishAH.Sudden cardiacdeathriskstratificationinpatientswithnonischemicdilated cardiomyopathy.JAmCollCardiol2014;63:1879–1889.

373.ElliottPM,AnastasakisA,BorgerMA,BorggrefeM,CecchiF,Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, MogensenJ,NihoyannopoulosP,NistriS,PieperPG,PieskeB,Rapezzi C,RuttenFH,TillmannsC,WatkinsH.2014ESCGuidelinesondiagnosis andmanagementofhypertrophiccardiomyopathy:TheTaskForcefor

444

КЛИНИЧЕСКИЕРЕКОМЕНДАЦИИПОПРОВЕДЕНИЮ ЭЛЕКТРОФИЗИОЛОГИЧЕСКИХПРОЦЕДУР УПАЦИЕНТОВСНАРУШЕНИЯМИРИТМАСЕРДЦА

theDiagnosisandManagementofHypertrophicCardiomyopathyofthe EuropeanSocietyofCardiology(ESC).EurHeartJ2014;35:2733–2779.

374.BhandariAK,ShapiroWA,MoradyF,ShenEN,MasonJ,Scheinman MM.ElectrophysiologictestinginpatientswiththelongQTsyndrome. Circulation1985;71:63–71.

375.GiustettoC,SchimpfR,MazzantiA,ScroccoC,MauryP,AnttonenO, Probst V,BlancJJ,SbragiaP,DalmassoP,BorggrefeM,GaitaF. Long- termfollow-upofpatientswithshortQTsyndrome.JAmCollCardiol 2011;58:587–595.

376.MazzantiA,KanthanA,MonteforteN,MemmiM,BloiseR,Novelli V, MiceliC,O’RourkeS,BorioG,Zienciuk-KrajkaA,CurcioA,Surducan AE,ColomboM,NapolitanoC,PrioriSG.Novelinsightintothenatural historyofshortQTsyndrome.JAmCollCardiol2014;63:1300–1308.

377.Brugada J, Brugada R, Brugada P. Determinants of sudden cardiac deathinindividualswiththeelectrocardiographicpatternofBrugada syndromeandnopreviouscardiacarrest.Circulation2003;108:3092– 3096.

378.PrioriSG,WildeAA,HorieM,ChoY,BehrER,BerulC,BlomN,Brugada J,ChiangCE,HuikuriH,KannankerilP,KrahnA,LeenhardtA,MossA, Schwartz PJ, Shimizu W, Tomaselli G, Tracy C. Executive summary: HRS/EHRA/APHRSexpertconsensusstatementonthediagnosisand managementofpatientswithinheritedprimaryarrhythmiasyndromes. Europace2013;15:1389–1406.

379.VolosinK,StadlerRW,WyszynskiR,KirchhofP. Tachycardiadetection performanceofimplantablelooprecorders:resultsfromalarge‘reallife’patientcohortandpatientswithinducedventriculararrhythmias. Europace2013;15:1215–1222.

380.ZamanS,NarayanA,ThiagalingamA,SivagangabalanG,ThomasS, Ross DL, Kovoor P. Significance of repeat programmed ventricular stimulationatelectrophysiologystudyforarrhythmiapredictionafter acutemyocardialinfarction.PacingClinElectrophysiol2014;37:795– 802.

381.Brembilla-PerrotB,Suty-SeltonC,HouriezP,ClaudonO,BeurrierD, delaChaiseAT.Valueofnon-invasiveandinvasivestudiesinpatients withbundlebranchblock,syncopeandhistoryofmyocardialinfarction. Europace2001;3:187–194.

382.DecheringDG,KochhauserS,WasmerK,ZellerhoffS,PottC,Kobe J, Spieker T, Piers SR, Bittner A, Monnig G, Breithardt G, Wichter T, Zeppenfeld K, Eckardt L. Electrophysiological characteristics

445

ГЛАВА3

of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm 2013;10:158–164.

383.CarbucicchioC,SantamariaM,TrevisiN,MaccabelliG,GiraldiF,Fassini G, Riva S, Moltrasio M, Cireddu M, Veglia F, Della Bella P. Catheter ablation for the treatment of electrical storm in patients with implantablecardioverter-defibrillators:short-andlong-termoutcomes inaprospectivesingle-centerstudy.Circulation2008;117:462–469.

384.Calkins H, Epstein A, Packer D, Arria AM, Hummel J, Gilligan DM, Trusso J, Carlson M, Luceri R, Kopelman H, Wilber D, Wharton JM, StevensonW. Catheterablationofventriculartachycardiainpatients with structural heart disease using cooled radiofrequency energy: results of a prospective multicenter study. Cooled RF Multi Center InvestigatorsGroup.JAmCollCardiol2000;35:1905–1914.

385.Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, Kralovec S, Sediva L, Ruskin JN, Josephson ME. Prophylactic catheter ablation for the prevention of defibrillator therapy.NEnglJMed2007;357:2657–2665.

386.KuckKH,SchaumannA,EckardtL,WillemsS,VenturaR,DelacretazE, PitschnerHF,KautznerJ,SchumacherB,HansenPS.Catheterablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomisedcontrolledtrial.Lancet2010;375:31–40.

387.Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ,FishbeinDP,PackerDL,MarkDB,LeeKL,BardyGH.Prognostic importanceofdefibrillatorshocksinpatientswithheartfailure.NEngl JMed2008;359:1009–1017.

388.Kamphuis HC, de Leeuw JR, Derksen R, Hauer RN, Winnubst JA. Implantable cardioverter defibrillator recipients: quality of life in recipientswithandwithoutICDshockdelivery:aprospectivestudy. Europace2003;5:381–389.

389.deBakkerJM,vanCapelleFJ,JanseMJ,TasseronS,VermeulenJT,de JongeN,LahporJR.Slowconductionintheinfarctedhumanheart. ‘Zigzag’courseofactivation.Circulation1993;88:915–926.

390.deChillouC,LacroixD,KlugD,Magnin-Poull I,MarquieC,MessierM, AndronacheM,KouakamC,SadoulN,ChenJ,AliotE,KacetS. Isthmus characteristicsofreentrantventriculartachycardiaaftermyocardial infarction.Circulation2002;105:726–731.

446

КЛИНИЧЕСКИЕРЕКОМЕНДАЦИИПОПРОВЕДЕНИЮ ЭЛЕКТРОФИЗИОЛОГИЧЕСКИХПРОЦЕДУР УПАЦИЕНТОВСНАРУШЕНИЯМИРИТМАСЕРДЦА

391.LittmannL,SvensonRH,GallagherJJ,SelleJG,ZimmernSH,Fedor JM,ColavitaPG.Functionalroleoftheepicardiuminpostinfarction ventricular tachycardia. Observations derived from computerized epicardial activation mapping, entrainment, and epicardial laser photoablation.Circulation1991;83:1577–1591.

392.Berruezo A, Mont L, Nava S, Chueca E, Bartholomay E, Brugada J. Electrocardiographicrecognitionoftheepicardialoriginofventricular tachycardias.Circulation2004;109:1842–1847.

393.DanielsDV,LuYY,MortonJB,SantucciPA,AkarJG,GreenA,Wilber DJ.Idiopathicepicardialleftventriculartachycardiaoriginatingremote fromthesinusofValsalva:electrophysiologicalcharacteristics,catheter ablation, and identification from the 12-lead electrocardiogram. Circulation2006;113:1659–1666.

394.Bazan V,GerstenfeldEP,GarciaFC,BalaR,RivasN,DixitS,ZadoE, Callans DJ, Marchlinski FE. Site-specific twelve-lead ECG features toidentifyanepicardialoriginforleftventriculartachycardiainthe absenceofmyocardialinfarction.HeartRhythm2007;4:1403–1410.

395.Valles E, Bazan V, Marchlinski FE. ECG criteria to identify epicardial ventriculartachycardiainnonischemiccardiomyopathy.CircArrhythm Electrophysiol2010;3:63–71.

396.ArenalA,Perez-DavidE,AvilaP,Fernandez-PortalesJ,Crisostomo V, Baez C, Jimenez-Candil J, Rubio-Guivernau JL, Ledesma-Carbayo MJ,LoughlinG,BermejoJ,Sanchez-MargalloFM,Fernandez-Aviles F. Noninvasive identification of epicardial ventricular tachycardia substrate by magnetic resonance-based signal intensitymapping. HeartRhythm2014;11:1456–1464.

397.Perez-David E, Arenal A, Rubio-Guivernau JL, del Castillo R, Atea L,ArbeloE,CaballeroE,Celorrio V,DatinoT,Gonzalez-TorrecillaE, AtienzaF,Ledesma-CarbayoMJ,BermejoJ,MedinaA,Fernandez- AvilesF. Noninvasiveidentificationofventriculartachycardia-related conductingchannelsusingcontrast-enhancedmagneticresonance imaginginpatientswithchronicmyocardialinfarction:comparison ofsignalintensityscarmappingandendocardialvoltagemapping.J AmCollCardiol2011;57:184–194.

398.BanschD,BockerD,BrunnJ,WeberM,BreithardtG,BlockM. Clusters ofventriculartachycardiassignifyimpairedsurvivalinpatientswith idiopathic dilated cardiomyopathy and implantable cardioverter defibrillators.JAmCollCardiol2000;36:566–573.

447

ГЛАВА3

399.HaissaguerreM,ExtramianaF,HociniM,CauchemezB,JaisP,Cabrera JA,FarreJ,LeenhardtA,SandersP,ScaveeC,HsuLF,WeerasooriyaR, ShahDC,FrankR,MauryP,DelayM,GarrigueS,ClementyJ. Mapping andablationofventricularfibrillationassociatedwith long-QTand Brugadasyndromes.Circulation2003;108:925–928.

400.BerruezoA,Fernandez-ArmentaJ,MontL,ZeljkoH,AndreuD,Herczku C,BoussyT,TolosanaJM,ArbeloE,BrugadaJ. Combinedendocardial andepicardialcatheterablationinarrhythmogenicrightventricular dysplasiaincorporatingscardechannelingtechnique.CircArrhythm Electrophysiol2012;5:111–121.

401.MarchlinskiFE,CallansDJ,GottliebCD,ZadoE. Linearablationlesions for control of unmappable ventricular tachycardia in patients with ischemicandnonischemiccardiomyopathy.Circulation2000;101:1288– 1296.

402.JaisP,MauryP,KhairyP,SacherF,Nault I,KomatsuY,HociniM,Forclaz A,JadidiAS,WeerasooryiaR,ShahA,DervalN,CochetH,KnechtS, MiyazakiS,LintonN,RivardL,WrightM,WiltonSB,ScherrD,Pascale P, Roten L, Pederson M, Bordachar P, Laurent F, Kim SJ, Ritter P, ClementyJ,HaissaguerreM. Eliminationoflocalabnormalventricular activities:anewendpointforsubstratemodificationinpatientswith scar-relatedventriculartachycardia.Circulation2012;125:2184–2196.

403.DiBiaseL,SantangeliP,BurkhardtDJ,BaiR,MohantyP,Carbucicchio C,DelloRussoA,CasellaM,MohantyS,PumpA,HongoR,BeheiryS, PelargonioG,SantarelliP,ZucchettiM,HortonR,SanchezJE,Elayi CS,LakkireddyD,TondoC,NataleA. Endo-epicardialhomogenization of the scar versus limited substrate ablation for the treatment of electricalstormsinpatientswithischemiccardiomyopathy.JAmColl Cardiol2012;60:132–141.

404.CanoO,HutchinsonM,LinD,GarciaF,ZadoE,BalaR,RileyM,Cooper J,DixitS,GerstenfeldE,CallansD,MarchlinskiFE.Electroanatomic substrateandablationoutcomeforsuspectedepicardialventricular tachycardiainleftventricularnonischemiccardiomyopathy.JAmColl Cardiol2009;54:799–808.

405.BaiR,DiBiaseL,ShivkumarK,MohantyP,TungR,SantangeliP,Saenz LC,VaccaM,VermaA,KhaykinY,MohantyS,BurkhardtJD,Hongo R, Beheiry S, Dello Russo A, Casella M, Pelargonio G, Santarelli P, Sanchez J, Tondo C, Natale A. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy:

448

КЛИНИЧЕСКИЕРЕКОМЕНДАЦИИПОПРОВЕДЕНИЮ ЭЛЕКТРОФИЗИОЛОГИЧЕСКИХПРОЦЕДУР УПАЦИЕНТОВСНАРУШЕНИЯМИРИТМАСЕРДЦА

arrhythmia-freesurvivalafterendo-epicardialsubstratebasedmapping andablation.CircArrhythmElectrophysiol2011;4:478–485.

406.McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM,PopescuBA, Ronnevik PK, Rutten FH, Schwitter J,SeferovicP, StepinskaJ,TrindadePT,VoorsAA,ZannadF,ZeiherA.ESCGuidelines forthediagnosisandtreatmentofacuteandchronicheartfailure2012: TheTaskForcefortheDiagnosisandTreatmentofAcuteandChronic HeartFailure2012oftheEuropeanSocietyofCardiology.Developed incollaborationwiththeHeartFailureAssociation(HFA)oftheESC. EurHeartJ2012;33:1787–1847.

407.CardiacArrhythmiaSuppressionTrial(CAST)Investigators.Preliminary report:effectofencainideandflecainideonmortalityinarandomized trialofarrhythmiasuppressionaftermyocardialinfarction.NEnglJ Med1989;321:406–412.

408.KuckKH,CappatoR,SiebelsJ,RuppelR. Randomizedcomparisonof antiarrhythmicdrugtherapywithimplantabledefibrillatorsinpatients resuscitatedfromcardiacarrest:theCardiacArrestStudyHamburg (CASH).Circulation2000;102:748–754.

409.O’Mahony C, Tome-Esteban M, Lambiase PD, Pantazis A, Dickie S, McKennaWJ,ElliottPM.Avalidationstudyofthe2003AmericanCollege of Cardiology/European Society of Cardiology and 2011 American CollegeofCardiologyFoundation/AmericanHeartAssociationrisk stratificationandtreatmentalgorithmsforsuddencardiacdeathin patientswithhypertrophiccardiomyopathy.Heart2013;99:534–541.

410.ConnollySJ,CammAJ,HalperinJL,JoynerC,AlingsM,AmerenaJ, AtarD,AvezumA,BlomstromP,BorggrefeM,BudajA,ChenSA,Ching CK, Commerford P, Dans A, Davy JM, Delacretaz E, Di Pasquale G, DiazR,DorianP,FlakerG,GolitsynS,Gonzalez-HermosilloA,Granger CB,HeidbuchelH,KautznerJ,KimJS,LanasF,LewisBS,MerinoJL, MorilloC,MurinJ,NarasimhanC,PaolassoE,ParkhomenkoA,Peters NS,SimKH,StilesMK,TanomsupS,ToivonenL,TomcsanyiJ,TorpPedersenC,TseHF,VardasP,VinereanuD,XavierD,ZhuJ,ZhuJR, Baret-CormelL,WeinlingE,StaigerC,YusufS,ChrolaviciusS,AfzalR, HohnloserSH.Dronedaroneinhigh-riskpermanentatrialfibrillation. NEnglJMed2011;365:2268–2276.

411.RodenDM.Drug-inducedprolongationoftheQTinterval.N Engl J Med2004;350:1013–1022.

449

ГЛАВА3

412.ChamberlainDA,JewittDE,JulianDG,CampbellRW,BoyleDM,Shanks RG.Oralmexiletineinhigh-riskpatientsaftermyocardialinfarction. Lancet1980;2:1324–1327.

413.WichterT,BorggrefeM,HaverkampW,Chen X,BreithardtG. Efficacyof antiarrhythmicdrugsinpatientswitharrhythmogenicrightventricular disease.Resultsinpatientswithinducibleandnoninducibleventricular tachycardia.Circulation1992;86:29–37.

414.Stevenson WG, Wilber DJ, Natale A, Jackman WM, Marchlinski FE, Talbert T, Gonzalez MD, Worley SJ, Daoud EG, Hwang C, Schuger C, Bump TE, Jazayeri M, Tomassoni GF, Kopelman HA, Soejima K, Nakagawa H. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia aftermyocardialinfarction:themulticenterthermocoolventricular tachycardiaablationtrial.Circulation2008;118:2773–2782.

415.Peichl P, Wichterle D, Pavlu L, Cihak R, Aldhoon B, Kautzner J. Complications of catheter ablation of ventricular tachycardia: a single-centerexperience.CircArrhythmElectrophysiol2014;7:684– 690.

416.ScottPA,BarryJ,RobertsPR,MorganJM.Brainnatriureticpeptidefor thepredictionofsuddencardiacdeathandventriculararrhythmias: ameta-analysis.EurJHeartFail2009;11:958–966.

417.TannerH,HindricksG,VolkmerM,FurnissS,Kuhlkamp V,LacroixD,C DEC,AlmendralJ,CaponiD,KuckKH,KottkampH. Catheterablationof recurrentscar-relatedventriculartachycardiausingelectroanatomical mappingandirrigatedablationtechnology:resultsoftheprospective multicenterEuro-VT-study.JCardiovascElectrophysiol2010;21:47–53.

418.Dinov B, Fiedler L, Schonbauer R, Bollmann A, Rolf S, Piorkowski C, Hindricks G, Arya A. Outcomes in catheter ablation of ventricular tachycardiaindilatednonischemiccardiomyopathycomparedwith ischemiccardiomyopathy:resultsfromtheProspectiveHeartCentre ofLeipzigVT(HELP-VT)Study.Circulation2014;129:728–736.

419.BlanckZ,DhalaA,DeshpandeS,SraJ,JazayeriM,AkhtarM. Bundle branchreentrantventriculartachycardia:cumulativeexperiencein48 patients.JCardiovascElectrophysiol1993;4:253–262.

420.Caceres J, Jazayeri M, McKinnie J, Avitall B, Denker ST, Tchou P, AkhtarM. Sustainedbundlebranchreentryasamechanismofclinical tachycardia.Circulation1989;79:256–270.

421.BardyGH,LeeKL,MarkDB,PooleJE,PackerDL,BoineauR,Domanski M,TroutmanC,AndersonJ,JohnsonG,McNultySE,Clapp-Channing

450